Trade

Abbott India share price

Balanced risk
  • 26%Low risk
  • 26%Moderate risk
  • 26%Balanced risk
  • 26%High risk
  • 26%Extreme risk
  • 34,185.75(0.02%)
    July 17, 2025 12:16:02 PM IST
    • NSE
    • BSE
  • Vol : 3.33K (NSE + BSE)
    Last 20 day avg : 12.73 K

Abbott India is trading 0.02% upper at Rs 34,185.75 as compared to its last closing price. Abbott India has been trading in the price range of 34,406.95 & 34,175.80. Abbott India has given 15.26% in this year & -0.32% in the last 5 days. Abbott India has TTM P/E ratio 46.15 as compared to the sector P/E of 23.12.There are 6 analysts who have initiated coverage on Abbott India. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 367.04 Crores in its last quarter.Listed peers of Abbott India include Zydus Lifesciences (1.31%), Lupin (1.45%), Abbott India (0.02%).The Mutual Fund holding in Abbott India was at 7.77% in 30 Jun 2025. The MF holding has increased from the last quarter. The FII holding in Abbott India was at 0.16% in 30 Jun 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 17, 2025, 07:14 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.37
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    17.44
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    52.18
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.07
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
34,175.80
Highest
34,406.95
52 week range
Lowest
25,260.20
Highest
35,921.55
Abbott India Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 11.54% from Rs 1604.59 crore to Rs 1438.63 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 27.86% from Rs 287.06 crore to Rs 367.04 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Abbott India Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 36,432.67
  • R2
  • 37,227.88
  • R3
  • 38,534.22
Pivot35,126.33
  • S1
  • 34,331.12
  • S2
  • 33,024.78
  • S3
  • 32,229.57
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Abbott India Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Zydus Lifesciences
Bullish
981.301.3198,741.7421.434.21.100.13
Lupin
Neutral
1,957.651.4589,409.0427.275.190.4111.80
Abbott India
Bullish
34,185.750.0272,827.1053.2117.781.343.73
Alkem Laboratories
Moderately Bullish
5,017.400.3559,934.4226.624.810.934.83
Glaxosmithkline Pharmaceutical
Neutral
3,177.400.4253,808.3260.5328.671.270.13
Abbott India Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Abbott India is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 74.99%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding is constant over the last quarter at 0.16%
    • InsightsMutual Funds holding has increased by 0.04 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 49.63
    • % of AUM 6.09
    SBI Magnum Global Fund Regular Growth
    NA
    • Amount Invested (Cr.) 274.10
    • % of AUM 4.31
    Samco Flexi Cap Fund Regular Growth
    1/5
    • Amount Invested (Cr.) 18.18
    • % of AUM 3.96
    NJ ELSS Tax Saver Scheme Regular Growth
    NA
    • Amount Invested (Cr.) 10.09
    • % of AUM 3.72
    SBI Innovative Opportunities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 262.05
    • % of AUM 3.56
    Abbott India Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-15Audited Results & Final Dividend
    2025-02-05Quarterly Results
    2024-11-07Quarterly Results
    2024-08-07Quarterly Results
    2024-05-09Audited Results & Final Dividend
    About the company Abbott India
    • IndustryBiotechnology & Drugs
    • ISININE358A01014
    • BSE Code500488
    • NSE CodeABBOTINDIA
    Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.
    • Management Info
    • Maithilee MistryChief Financial Officer
    • Devesh ChoudhariDirector - Finance
    • Sangeeta ShettyChief Compliance Officer, Company Secretary, Associate Director - Secretarial
    • Kartik RajendranManaging Director, Director
    • Prithwish BanerjiCommercial Director - Womens Health, Metabolics and International Business
    • Rajan KalantreDirector - Business Human Resources
    • Jejoe KarankumarDirector - Medical Affairs
    • Anushree KunhambuAssociate Director - New Product Introduction and Therapy Area Strategy
    • Anuj MehraCommercial Director - NeuroLife, GenNext and Vaccines
    • Richa TripathiAssociate Director - Sales Force Effectiveness, Project Management Office
    Abbott India Share Price FAQs

    Abbott India is trading at 34185.75 as on Thu Jul 17 2025 06:46:02. This is 0.02% upper as compared to its previous closing price of 34179.35.

    The market capitalization of Abbott India is 72827.10 Cr as on Thu Jul 17 2025 06:46:02.

    The 52 wk high for Abbott India is 35921.55 whereas the 52 wk low is 25260.20

    Abbott India can be analyzed on the following key metrics -

    • TTM P/E: 46.15
    • Sector P/E: 23.12
    • Dividend Yield: 1.39%
    • D/E ratio: 0.05

    Abbott India reported a net profit of 1414.44 Cr in 2025.

    The Mutual Fund Shareholding was 7.77% at the end of 30 Jun 2025.